---
title: "Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)"
date: "2025-09-09T04:00:00.000Z"
publishedDate: "9 septembre 2025"
summary: "Conditions : Tuberculosis (TB) Interventions : Drug: Isoniazid (H); Drug: Rifampicin (R); Drug: Pyrazinamide (Z); Drug: Ethambutol (E) Sponsors : University College, London; National University of Medical Sciences, Pakistan; Aurum Institute; Biomedical Research and Training Institute, Zimbabwe; Foundation for Innovative New Diagnostics, Switzerland; KTH Royal Institute of Technology; London School of Hygiene and Tropical Medicine; Wits Health Consortium (Pty) Ltd Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07163143?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-09-optimal-treatment-duration-for-radiographically-apparent-bacteriologically-unconfirmed-tb-identified-through-active-case-finding-radio-tb-trial"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Tuberculosis (TB) Interventions : Drug: Isoniazid (H); Drug: Rifampicin (R); Drug: Pyrazinamide (Z); Drug: Ethambutol (E) Sponsors : University College, London; National University of Medical Sciences, Pakistan; Aurum Institute; Biomedical Research and Training Institute, Zimbabwe; Foundation for Innovative New Diagnostics, Switzerland; KTH Royal Institute of Technology; London School of Hygiene and Tropical Medicine; Wits Health Consortium (Pty) Ltd Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07163143?term=interventional+radiology&aggFilters=status%3A
